CYP2D6 and Antidepressants: Why Your SSRI Might Not Work
The pharmacogenomics test that could change your mental health treatment
By GenomeInsight Science Team
Key Takeaways
- 5-10% of people are CYP2D6 Poor Metabolizers — standard antidepressant doses can cause dangerous side effects
- 1-10% are Ultrarapid Metabolizers — the drug is cleared too fast to be effective
- CPIC provides evidence-based dosing guidelines for >10 antidepressants based on CYP2D6 status
- Good alternatives for PMs: sertraline, citalopram, escitalopram, mirtazapine, bupropion (not CYP2D6 dependent)
- Never change medications without consulting your prescriber — share your report with them
Why Do Antidepressants Work for Some People and Not Others?
Nearly 70% of patients don't respond adequately to their first antidepressant. The standard approach — trial-and-error prescribing — can mean months or years of suffering through ineffective medications and unnecessary side effects.
One major reason: your CYP2D6 gene determines how fast your liver breaks down many antidepressants. If you metabolize a drug too quickly, it never reaches effective levels. If too slowly, the drug accumulates and causes side effects.
CYP2D6 is the most genetically variable drug-metabolizing enzyme, with over 100 known allelic variants. Your combination of alleles (diplotype) determines your "metabolizer status."
CYP2D6 Metabolizer Types
| Status | Activity Score | % of Population | What It Means |
|---|---|---|---|
| Ultrarapid (UM) | >2.25 | 1-10%* | Breaks down drugs extremely fast — subtherapeutic levels |
| Normal (NM) | 1.25-2.25 | 40-55% | Standard drug metabolism — standard dosing works |
| Intermediate (IM) | 0.25-1.0 | 20-40% | Slower metabolism — may need lower doses |
| Poor (PM) | 0 | 5-10% | Cannot metabolize — drug accumulates, high side effect risk |
*UM frequency varies dramatically by ethnicity: ~1% Northern European, ~10% Southern European, ~29% Ethiopian/Eritrean
How to read your GenomeInsight CYP2D6 result:
- •*1 (normal): 1.0
- •*2 (normal): 1.0
- •*4 (non-functional): 0
- •*6 (non-functional): 0
- •*10 (decreased): 0.25
- •*41 (decreased): 0.5
Your total activity score = sum of both alleles.
Affected Antidepressants (CPIC Guidelines)
SSRIs: | Drug | PM Guidance | UM Guidance | |------|------------|-------------| | Fluoxetine (Prozac) | Reduce dose by 50% or use alternative | Standard dosing | | Paroxetine (Paxil) | Consider alternative SSRI not metabolized by CYP2D6 | Standard dosing | | Fluvoxamine (Luvox) | Consider 25-50% dose reduction | Standard dosing |
SNRIs & Tricyclics: | Drug | PM Guidance | UM Guidance | |------|------------|-------------| | Venlafaxine (Effexor) | Consider dose reduction or switch to desvenlafaxine | Consider dose increase or alternative | | Amitriptyline (Elavil) | Avoid or reduce dose 50%, consider nortriptyline | Avoid — reduced efficacy likely | | Nortriptyline | Reduce dose 50%, monitor levels | Avoid — subtherapeutic levels | | Desipramine | Reduce dose 50%, monitor levels | Consider dose increase |
Antidepressants NOT affected by CYP2D6: These are good alternatives for PMs: sertraline (Zoloft), citalopram (Celexa), escitalopram (Lexapro), mirtazapine (Remeron), bupropion (Wellbutrin), desvenlafaxine (Pristiq).
Note: sertraline and citalopram are metabolized by CYP2C19 — check that gene too.
What to Do With Your Results
If you're a CYP2D6 Poor Metabolizer (PM): 1. Don't stop any medication abruptly — always consult your prescriber first 2. Share your GenomeInsight pharmacogenomics report with your doctor or pharmacist 3. Ask about dose adjustments or alternative medications based on CPIC guidelines 4. Consider getting confirmatory clinical-grade PGx testing (e.g., GeneSight, OneOme)
If you're considering starting an antidepressant:
- •Knowing your CYP2D6 status BEFORE starting can save months of trial-and-error
- •Ask your doctor: "Should we check pharmacogenomics before choosing a medication?"
- •If they're unfamiliar, point them to cpicpgx.org for evidence-based dosing guidelines
Important caveats:
- •Consumer genotyping (23andMe/AncestryDNA) doesn't test all CYP2D6 variants
- •Gene duplications/deletions (common in CYP2D6) aren't reliably detected by genotyping arrays
- •Drug-drug interactions can change your effective metabolizer status (e.g., fluoxetine inhibits CYP2D6)
- •Pharmacogenomics is one piece of the puzzle — clinical response, side effects, and patient preference all matter
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Genetic information should be interpreted in the context of your full medical history by a qualified healthcare provider. Never change medications without consulting your doctor.
References
- [1]Hicks JK et al. (2015). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants. Clin Pharmacol Ther. 98(2):127-34.PubMed
- [2]Hicks JK et al. (2017). Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of SSRIs. Clin Pharmacol Ther. 102(1):37-44.PubMed
- [3]Caudle KE et al. (2020). Standardizing CYP2D6 Genotype to Phenotype Translation. J Transl Med. 18:305.PubMed
- [4]Rush AJ et al. (2006). STAR*D Study: Acute and Longer-Term Outcomes in Depressed Outpatients. Am J Psychiatry. 163(11):1905-17.PubMed
Check your drug metabolism
Upload your 23andMe or AncestryDNA raw data to see your personal results. Processing happens entirely in your browser — no data leaves your device.
Analyze Your DNA Free